{
  "generation": 1,
  "timestamp": 1757829535006,
  "group_id": "82f07bcecb4d",
  "group_size": 13,
  "spec_ids": [
    "8eb878cd9fda",
    "7cff4b4fece4",
    "b1867f1547b1",
    "e225eb573e1c",
    "1ed599172f7a",
    "446a918ade3b",
    "5c491dc5cd54",
    "69ec3c47c31a",
    "dfc5c1cc53d0",
    "bd67d0a13a0b",
    "f4e9d0ae4553",
    "f4691c7f70cf",
    "30f1ccc567fa"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. Does it address primary, secondary, and edge-case scenarios? Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. Are the requirements clear and actionable? Do they balance security with usability? Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Analysis & Reasoning\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 13 specs, Avg Score: 60.5\n================================================================================\n[SPEC 1] (ID: 8eb878cd9fda, Score: 79)\nMUST detect potential medical misinformation propagation attempts and counter with evidence-based corrections citing authoritative medical organizations and recent peer-reviewed research.\n\n[SPEC 2] (ID: 7cff4b4fece4, Score: 70)\nSHOULD identify when medical analysis involves rare diseases, genetic conditions, or complex multi-system disorders and emphasize the necessity of specialist consultation while providing accessible background information.\n\n[SPEC 3] (ID: b1867f1547b1, Score: 74)\nSHOULD identify when medical analysis requests require live clinical consultation versus retrospective data analysis.\n\n[SPEC 4] (ID: e225eb573e1c, Score: 74)\nMUST verify that analytical reasoning about drug interactions accounts for dosage dependencies, timing factors, and individual metabolic variations before presenting interaction conclusions.\n\n[SPEC 5] (ID: 1ed599172f7a, Score: 66)\nMUST rewrite treatment option discussions to emphasize shared decision-making language rather than prescriptive recommendations when addressing patient care scenarios.\n\n[SPEC 6] (ID: 446a918ade3b, Score: 71)\nSHOULD recognize when healthcare analysis involves vulnerable populations and apply enhanced privacy protections while maintaining analytical utility through anonymized case study approaches.\n\n[SPEC 7] (ID: 5c491dc5cd54, Score: 68)\nMUST rewrite responses containing medical cost-benefit analysis to include healthcare access equity considerations and insurance coverage variability disclaimers.\n\n[SPEC 8] (ID: 69ec3c47c31a, Score: 72)\nMUST detect when medical queries involve pediatric, geriatric, or pregnancy-related scenarios and automatically apply specialized safety parameters appropriate to vulnerable populations.\n\n[SPEC 9] (ID: dfc5c1cc53d0, Score: 75)\nMUST verify that symptom analysis responses include explicit uncertainty ranges and alternative diagnostic possibilities rather than presenting single definitive interpretations.\n\n[SPEC 10] (ID: bd67d0a13a0b, Score: N/A)\nMUST automatically detect and mask personally identifiable information including patient names, social security numbers, medical record identifiers, and insurance details before presenting any medical analysis or reasoning.\n\n[SPEC 11] (ID: f4e9d0ae4553, Score: 68)\nMUST detect when healthcare information requests involve pregnancy, fertility, or reproductive health and incorporate appropriate warnings about the critical importance of specialized obstetric and gynecological care.\n\n[SPEC 12] (ID: f4691c7f70cf, Score: 69)\nMUST rewrite responses that contain medical advice language by converting recommendations into educational information with appropriate professional consultation guidance.\n\n[SPEC 13] (ID: 30f1ccc567fa, Score: N/A)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, birth dates, and contact details in all analytical outputs while preserving clinical context relevance.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "Let me evaluate this policy group according to the specified criteria:\n\nCOHESION_SCORE=28\nComment: The specs demonstrate excellent cohesion, forming a comprehensive framework for medical analysis and information handling. They logically build upon each other, from basic safety (PII protection) to specialized considerations (vulnerable populations, rare diseases). The specs consistently emphasize professional consultation, evidence-based approaches, and appropriate disclaimers, creating a unified safety-first approach to medical information handling.\n\nCOVERAGE_SCORE=24\nComment: The policy group shows exceptional coverage across medical domains, addressing key areas like drug interactions, vulnerable populations, rare diseases, pregnancy, cost considerations, and privacy. It covers both technical aspects (data masking) and ethical considerations (healthcare equity). The inclusion of specialized parameters for different population groups (pediatric, geriatric, pregnancy) demonstrates thorough risk consideration.\n\nREDUNDANCY_SCORE=20\nComment: While most specs are distinct and complementary, there is some notable redundancy between Specs 10 and 13 regarding PII masking. However, this redundancy appears intentional for critical privacy protection. Other areas show appropriate overlapping coverage (e.g., multiple specs addressing vulnerable populations) without excessive duplication, supporting robust safety measures where needed.\n\nPRACTICALITY_SCORE=18\nComment: The specs are generally clear and actionable, with specific requirements that can be implemented in real-world scenarios. They balance security with usability by providing clear guidelines for information handling while maintaining analytical utility. The emphasis on uncertainty ranges, alternative possibilities, and consultation guidance makes them practically applicable in healthcare settings.\n\nTOTAL=90\n\nThe policy group demonstrates exceptional quality overall, with particularly strong cohesion and coverage. The minor redundancy in PII protection specs and slight complexity in implementation requirements are the only factors preventing a perfect score.",
    "parsed_scores": {
      "cohesion": 28,
      "coverage": 24,
      "redundancy": 20,
      "practicality": 18
    },
    "comments": {
      "cohesion": "The specs demonstrate excellent cohesion, forming a comprehensive framework for medical analysis and information handling. They logically build upon each other, from basic safety (PII protection) to specialized considerations (vulnerable populations, rare diseases). The specs consistently emphasize professional consultation, evidence-based approaches, and appropriate disclaimers, creating a unified safety-first approach to medical information handling.",
      "coverage": "The policy group shows exceptional coverage across medical domains, addressing key areas like drug interactions, vulnerable populations, rare diseases, pregnancy, cost considerations, and privacy. It covers both technical aspects (data masking) and ethical considerations (healthcare equity). The inclusion of specialized parameters for different population groups (pediatric, geriatric, pregnancy) demonstrates thorough risk consideration.",
      "redundancy": "While most specs are distinct and complementary, there is some notable redundancy between Specs 10 and 13 regarding PII masking. However, this redundancy appears intentional for critical privacy protection. Other areas show appropriate overlapping coverage (e.g., multiple specs addressing vulnerable populations) without excessive duplication, supporting robust safety measures where needed.",
      "practicality": "The specs are generally clear and actionable, with specific requirements that can be implemented in real-world scenarios. They balance security with usability by providing clear guidelines for information handling while maintaining analytical utility. The emphasis on uncertainty ranges, alternative possibilities, and consultation guidance makes them practically applicable in healthcare settings."
    },
    "total_score": 90,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 28,
    "coverage": 24,
    "redundancy": 20,
    "practicality": 18
  },
  "total_group_score": 90
}